PF-06648671

• Description:

  PF-06648671 (PF6648671) is a novel oral γ-secretase modulator being developed for the treatment of Alzheimer's disease.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  538.928

• Molecular Formula:

  C25H23ClF4N4O3

• Notes:

  Research use only, not for human use.

• Receptor:

  Γ-secretase

• CAS Number:

  1587727-31-8